This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US

Early Registration Savings Deadline Expires In

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event
September 27-30, 2022Boston Convention and Exhibition Center

Ken Green, PhD
Snr Dir, MSAT-Commercial Manufacturing & Supply Chain at Vertex


Responsibility for MSAT team at Vertex supporting cell and gene therapies within Commercial Manufacturing & Supply Chain. Gained over 25 years in Biotechnology/Pharma industry leading technical functions covering all phases of process/analytical development and commercial product operations at Samsung Biologics, Shire, Pfizer, Amgen, Lonza and GSK.

Have a passion for continuous improvement with application of six and lean sigma methodologies for efficiency gains, problem solving and strategy deployment. Graduated with a degree in Microbiology from University of Sheffield, UK, followed by MSc and PhD degrees in Biochemical Engineering from University of Birmingham, UK.

Agenda Sessions

  • Commercial Manufacturing Readiness for a Autologous Gene Edited Cell Therapy


Speakers at this event